Brief: Theradiag announces strategic agreement with Miraca Life Sciences in the USA
Nov 18 (Reuters) - Theradiag SA ALTHE.PA :
* Announced strategic licensing agreement with Miraca Life
Sciences (MLS) to offer in U.S. Theradiag's flagship therapeutic
drug monitoring assays
* Theradiag will sell raw materials to MLS and will receive
royalties on MLS' sales in U.S
Source text for Eikon: ID:nBw2vxzQla
Further company coverage: ALTHE.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))